POSTERS ASCO 2024

Cáncer de mama

Local, regional y adyuvante

Ipatasertib (IPA) combined with non-taxane chemotherapy (CT) for patients (pts) with previously treated advanced triple-negative breast cancer (aTNBC): The PATHFINDER phase IIa trial.

Cáncer de mama

Ipatasertib (IPA) combined with non-taxane chemotherapy (CT) for patients (pts) with previously treated advanced triple-negative breast cancer (aTNBC): The PATHFINDER phase IIa trial.

Abstract: 1098 Poster Bd #: 76

Poster

Autor

María Gion, MD

Hospital Universitario Ramón y Cajal

Compartir:

Una iniciativa científica de:

Con el patrocinio de:

REGENERON